Dr. Jeremy D. Wolfe, MD

Dr. Wolfe practices at Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan.

Dr. Wolfe's NPI, 1356365514, was assigned on July 27, 2006. Dr. Wolfe graduated from Medical College of Ohio in 2004. Dr. Wolfe holds Michigan license 4301096407.

Dr. Wolfe's primary practice is Beaumont Neuroscience Center - Royal Oak, at 3555 W 13 Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 551-2250.

Dr. Wolfe's primary practice is Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan. Dr. Wolfe is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Wolfe to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfe practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Wolfe's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Wolfe is licensed in Michigan.

CMS data shows 70,100 Medicare services from Dr. Wolfe across 21 procedure codes in 2024, for 790 Medicare patients. Medicare paid $3,810,201 for them.

CMS counts 790 Medicare patients who saw Dr. Wolfe in 2024. The largest group is 65 to 74, with 301 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolfe's median patient age at 74, with 55% women.

In 2024, Dr. Wolfe wrote 382 Medicare Part D claims for 160 patients. 59% of them were for generic drugs. CMS names the drug for 322 of them, across 7 drugs with 11 or more claims each, at $10,940 in total drug cost. In 2023, CMS named 271 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Wolfe for performance year 2024, reported as part of a group. Dr. Wolfe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of cataract surgery by Dr. Wolfe, more than 39% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Wolfe, published from 2019 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Vitrectomy and Angiogenesis Inhibitors. Dr. Wolfe has published most often in Retina. Dr. Wolfe's most frequent co-authors are Antonio Capone, MD, Lisa Jane Faia, MD and Tarek Shawky Hassan, MD.

CMS Open Payments shows 958 general payments to Dr. Wolfe from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Genentech, Inc. paid the most, $343,399. It also lists 3 research payments totaling $6,917 in 2024.

Dr. Wolfe graduated from Medical College of Ohio in 2004.